Kiromic BioPharma has lower revenue, but higher earnings than Finch Therapeutics Group. Finch Therapeutics Group is trading at a lower price-to-earnings ratio than Kiromic BioPharma, indicating ...

Shares of Mereo BioPharma Group stock opened at $2.30 on Thursday. The firm has a 50-day moving average of $2.72 and a 200-day moving average of $3.49. Mereo BioPharma Group has a 52-week low of ...

Argentum has acquired Marelius Biopharma Group (MBG), a UK-based company specializing in training and educational services for the biopharmaceutical and pharmaceutical sectors. Through this all ...

Fintel reports that on October 31, 2024, Maxim Group downgraded their outlook for Matinas BioPharma Holdings (NYSEAM:MTNB) from Buy to Hold. Analyst Price Forecast Suggests 6,481.71% Upside As of ...

For more information, visit www.sequoiabiotech.com. Syner-G BioPharma Group is a premier provider of comprehensive services in product development, regulatory strategy and submissions ...

For more information, visit www.sequoiabiotech.com. Syner-G BioPharma Group is a premier provider of comprehensive services in product development, regulatory strategy and submissions, functional ...